Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/18/11 → 01/12/16 |
Funding
- Brigham and Womens Hospital: $66,757.25
ASTRAZENECA: A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events with Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy ...
- Lawson, William (CoPI)
- Gruberg, Luis (PI)
- Chernilas, Joseph (CoPI)
- Jeremias, Allen (CoPI)
- Mani, Anil (CoPI)
Project: Research